Patent Assignment
Reel/Frame 055845/0618
Confirmatory Grant of Security Interest in United States Patents
Recorded: 2021-04-06
Pages: 12
Assignors
BIOSPECIFICS TECHNOLOGIES LLC
Executed: 2021-03-29
PAR PHARMACEUTICAL, INC.
Executed: 2021-03-29
AUXILIUM US HOLDINGS, LLC
Executed: 2021-03-29
ASTORA WOMEN'S HEALTH, LLC
Executed: 2021-03-29
ENDO PHARMACEUTICALS SOLUTIONS INC.
Executed: 2021-03-29
ENDO PHARMACEUTICALS, INC.
Executed: 2021-03-29
Assignee
WILMINGTON TRUST, NATIONAL ASSOCIATION
1100 NORTH MARKET STREET, WILMINGTON, DELAWARE, 19890
Covered Properties
(35)
System for Osmotic Delivery of Pharmaceutically Active Agents
Selective Nerve Fiber Stimulation for Treating Heart Conditions
Sustained Release Formulations of Metformin
Delayed Release Dosage Forms
Heating Method for Tissue Contraction
Systems, Apparatus and Associated Methods for Needleless Delivery of Therapeutic Fluids
Sulfonic Acid and Aldehyde Condensation Polymers for the Treatment and Prevention of Hpv
Needleless Injection Device Components, Systems, and Methods
Devices, Systems, and Methods for Delivering Fluid to Tissue
Needleless Delivery Systems
Systems, Apparatus and Associated Methods for Needleless Delivery of Therapeutic Fluids
Injection Tube for Jet Injection Device
High Pressure Delivery System and Method for Treating Pelvic Disorder Using Large Molecule Therapeutics
Implantable Article and Method
Systems and Methods for Treating a Pelvic Disorder
Stabilized Compositions Containing Alkaline Labile Drugs
Devices, Systems, and Methods for Delivering Fluid to Tissue
Method and Apparatus for Compensating for Injection Media Viscosity in a Pressurized Drug Injection System
Crystalline, Anhydrous Forms of Oxymorphone Hydrochloride
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Sustained Release Formulations of Nalbuphine
Delivery of Dry Formulations of Octreotide
Application:
16/564,922 →
Publication:
US 2019/0388500
Compositions and Methods for Treating Precocious Puberty
Application:
16/793,391 →
Publication:
US 2020/0179480
Epinephrine Formulations
Method to Treat Hypotension Using Vasopressin in Certain Genotypes
Patent:
10,844,435 →
Application:
16/932,351 →
Controlled Release Formulations of Octreotide
Application:
16/942,309 →
Publication:
US 2020/0353055
Oxymorphone Controlled Release Compositions
Application:
17/035,453 →
Publication:
US 2021/0008063
Treatment Method and Product for Uterine Fibroids using Purified Collagenase
Application:
17/064,126 →
Publication:
US 2021/0023014
Method to Treat Hypotension Using Vasopressin in Certain Genotypes
Patent:
10,920,278 →
Application:
17/070,103 →
Treatment of Uterine Fibroids using Purified Collagenase
Thermosensitive Hydrogel Collagenase Formulations
Application:
17/083,650 →
Publication:
US 2021/0060143
Treatment of Uterine Fibroids using Purified Collagenase
Application:
62/915,360 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →
Release of Patent Security Interest
Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
Grant of Security Interest in Patents
Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
Release of Security Interest
Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
Release of Security Interest
Nov 30, 2017
From: U.S. BANK NATIONAL ASSOCIATION
To: SUPERNUS PHARMACEUTICALS, INC.
Reel/Frame 044552/0694 →
Assignment of Assignor's Interest
Jul 18, 2018
From: BIOCONTROL ,EDICAL (B.C.M.) LTD
To: MEDTRONIC, INC.
Reel/Frame 046574/0208 →
Change of Name
Jul 24, 2018
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 046620/0396 →
Assignment of Assignor's Interest
Jul 24, 2018
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 046620/0411 →
Assignment of Assignor's Interest
Jul 24, 2018
From: MELLIER, GEORGES
To: AMS RESEARCH CORPORATION
Reel/Frame 046444/0317 →
Change of Name
Jul 24, 2018
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 047250/0057 →
Confirmatory Grant of Security Interest in United States Patents
Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055846/0246 →
Merger and Change of Name
May 6, 2021
From: PENWEST PHARMACEUTICALS CO.; ENDO PHARMACEUTICALS INC.
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 056159/0769 →
Change of Name
Jul 30, 2021
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 057434/0848 →
Assignment of Assignor's Interest
Jul 30, 2021
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 057034/0731 →
Change of Name
Jul 30, 2021
From: AMS RESEACH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 057045/0949 →
Confirmatory Grant of Security Interest in United States Patents
Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
Assignment of Assignor's Interest
Apr 23, 2024
From: ASTORA WOMEN’S HEALTH, LLC
To: ENDO USA, INC.
Reel/Frame 067202/0768 →
Assignment of Assignor's Interest
Apr 23, 2024
From: ENDO PHARMACEUTICALS INC.
To: ENDO USA, INC.
Reel/Frame 067203/0398 →
Release of Security Interest
Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC
Reel/Frame 067239/0491 →
Release of Security Interest
Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC
Reel/Frame 067239/0542 →
Release of Security Interest
Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC
Reel/Frame 067239/0795 →
Release of Security Interest
Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
Assignment of Assignor's Interest
Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
Security Interest
Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
Security Interest
Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →